Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154009 · ClinicalTrials.gov registry record
Clinical Autonomic Disorders: A Training Protocol
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Terminated
- Registry status
- 21
- Enrollment target
NCT02154009: Clinical Trial study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT02154009 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154009 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Background: \- The autonomic nervous system helps control things that happen automatically in the body, like blood pressure, heart rate, and digestion. When it doesn t work properly, it s called dysautonomia. Researchers want to learn more about dysautonomias and train doctors to learn how to better diagnose them. Objectives: * To allow people with autonomic disorders to be evaluated. * To help fellows in the NIH Autonomic Disorders fellowship program see a variety of diseases in their training. Eligibility: * People age 18 and older with dysautonomia; children over age 2 if they might benefit * Healthy adult volunteers Design: * Participants will have different procedures depending on their symptoms. They will have one or more visits. They will have some but not all of the tests below. * Participants will have a medical history and physical exam. They may be tested for problems thinking. They may complete a symptom questionnaire. They may have their temperature and blood pressure taken. * Participants may have an intravenous line placed. A needle will guide a thin plastic tube into an arm vein. * Participants may have blood drawn several times. They may give a urine sample. * Participants may have an electrocardiogram. * How much blood a participant s heart is pumping and/or how much blood is flowing through their arm may be measured. The total amount of blood in their bloodstream may be measured. * Participants may have their ability to sweat and/or sense of smell tested. * Breathing, bowel sounds, and/or body functions may be monitored. * Pupil size, response to environmental temperature changes, and/or breathing may be measured. * Participants may have a bladder ultrasound. * Small pieces of skin may be taken for study.
Primary Outcome
Competency in clinical and laboratory evaluation of autonomic disorders, based on assessment of the Fellow by the Principal Investigator at approximately 6-month intervals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-06-05 |
| Est. Completion | 2021-04-07 |
Why NCT02154009 stopped before completion
NCT02154009 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02154009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154009 about?
NCT02154009 is a clinical study titled "Clinical Autonomic Disorders: A Training Protocol". Background: \- The autonomic nervous system helps control things that happen automatically in the body, like blood pressure, heart rate, and digestion. When it doesn t work properly, it s called dysautonomia. Researchers want to learn more about dysautonomias and train doctors to learn how to bette...
What is the current status of trial NCT02154009?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2014-06-05. Estimated completion is 2021-04-07.
Who is sponsoring clinical trial NCT02154009?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI